Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006118
Status:
UNKNOWN
Last Update Posted:
2008-07-24
First Post:
2000-08-03
Brief Title:
Cisplatin Paclitaxel and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer
Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000068131
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None